Experimental pulmonary emphysema induced in the rat by intratracheally administered elastase: morphogenesis

Area of Science:

• Pulmonary Medicine
• Toxicology
• Animal Models

Background:

• Emphysema is a chronic lung disease characterized by alveolar destruction.
• Porcine pancreatic elastase is a common agent used to experimentally induce emphysema.
• Understanding optimal induction methods is crucial for studying emphysema pathogenesis and potential treatments.

Purpose of the Study:

• To determine the optimal dose of porcine pancreatic elastase for inducing emphysema in rats.
• To evaluate the dose-response relationship between elastase administration and emphysema severity.
• To assess the impact of higher elastase doses on mortality and adverse effects.

Main Methods:

• Rats were administered varying doses of porcine pancreatic elastase (75, 100, 125, 150 units/100 g body weight).
• Emphysema induction was assessed by lesion morphogenesis and quantifiable degree of emphysema.
• Mortality rates, hemorrhage, and edema were monitored post-administration.

Main Results:

• All tested doses of elastase were effective in producing emphysema.
• Doses exceeding 75 units/100 g body weight offered no additional benefit for emphysema severity.
• Higher doses led to increased hemorrhage, edema, and post-instillation mortality.
• A 75-unit dose produced a consistent and quantifiable degree of emphysema.

Conclusions:

• The optimal dose for inducing emphysema in rats using porcine pancreatic elastase is 75 units/100 g body weight.
• Higher doses are not recommended due to increased adverse effects and mortality.
• Individual animal susceptibility and elastase batch variations necessitate dose-range studies for each new animal group.